FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:728-729 March 14, 1996 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Many factors influence the survival of patients with hepatocellular carcinoma, quite apart from treatment, the most important being the size of the tumor at the time of diagnosis and the severity of the underlying cirrhosis.¹ Small hepatocellular carcinomas have relatively long tumor-doubling times, as compared with large, symptomatic hepatocellular carcinomas. In a recent study, the three-year survival rate among 260 patients with well-compensated cirrhosis and hepatocellular carcinomas 5 cm or less in diameter was 79 percent with surgical treatment and 26 percent without treatment; among 131 patients with more advanced liver disease, the comparable rates were 40 percent and 13 . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Hussain, S. M., Zondervan, P. E., IJzermans, J. N. M., Schalm, S. W., de Man, R. A., Krestin, G. P. (2002). Benign versus Malignant Hepatic Nodules: MR Imaging Findings with Pathologic Correlation. RadioGraphics 22: 1023-1036 [Abstract] [Full Text]